Company intelligence / Profile preview

CMS Skinhealth

Haikou, Hainan, Chinaweb.cms.net.cn ↗
Ownership
Private
Development stage
Other
01

Overview

CMS Skinhealth has successfully commercialized several innovative drugs in China, including tildrakizumab injection (ILUMETRI) for moderate-to-severe plaque psoriasis and ruxolitinib cream for nonsegmental vitiligo. The company also holds exclusive licenses to multiple regenerative medical aesthetic injectable products currently in registrational clinical trials. Their clinical programs have demonstrated efficacy and safety consistent with global standards; ILUMETRI's PASI75 response rate continued to increase over time in Chinese phase III studies.[1][2][5]

Therapeutic areas
DermatologyImmunology
Modalities
Small molecule drugMonoclonal antibodyMedical device (injectable fillers, aesthetic devices)Regenerative medical aesthetic products
Industry
Biotech
02

Partnerships

Jiangsu Xihong Biopharma Co., Ltd.: exclusive license agreements for regenerative fillers[6].Hunan Mabgeek Biotechnology Co., Ltd.: co-development rights to anti–IL‑4Rα monoclonal antibody MG-K10.[4]

Beyond the preview

Go deeper on CMS Skinhealth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMS Skinhealth.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call